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Missense single-nucleotide polymorphisms (mSNPs) in titin are emerging as a
main causative factor of heart failure. However, distinguishing between benign
and disease-causing mSNPs is a substantial challenge. Here, we research the
question of whether a single mSNP in a generic domain of titin can affect
heart function as a whole and, if so, how. For this, we studied the mSNP
T2850I, seemingly linked to arrhythmogenic right ventricular cardiomyopathy
(ARVC). We used structural biology, computational simulations and trans-
genic muscle in vivo methods to track the effect of the mutation from the
molecular to the organismal level. The data show that the T2850I exchange is
compatible with the domain three-dimensional fold, but that it strongly desta-
bilizes it. Further, it induces a change in the conformational dynamics of the
titin chain that alters its reactivity, causing the formation of aberrant inter-
actions in the sarcomere. Echocardiography of knock-in mice indicated a
mild diastolic dysfunction arising from increased myocardial stiffness. In con-
clusion, our data provide evidence that single mSNPs in titin’s I-band can alter
overall muscle behaviour. Our suggested mechanisms of disease are the devel-
opment of non-native sarcomeric interactions and titin instability leading to a
reduced I-band compliance. However, understanding the T2850I-induced
ARVC pathology mechanistically remains a complex problem and will require
a deeper understanding of the sarcomeric context of the titin region affected.
1. Introduction
Cardiovascular disease is the major cause of death worldwide. Evidence accu-
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genetic mutation as an important factor in cardiomyopathy.
Titin mutations have now been linked to familial dilated car-
diomyopathy (DCM), hypertrophic cardiomyopathy (HCM)
and arrhythmogenic right ventricular cardiomyopathy
(ARVC) (recently reviewed in [1]). Pathogenicity often results
from mutations that lead to the truncation of the titin chain,
as identified in 25% of familial cases of idiopathic DCM
and 18% of sporadic cases [2]. Several missense single-
nucleotide polymorphisms (mSNPs) in titin have also been
associated with heart disease. These comprise the ARVC-
linked T2850I in the I-band [3]; the DCM-associated V54M,
A743V in the Z-disc [4] and W930R in the Z-disc/I-band tran-
sition zone [5]; R740L [6] and S3799Y [7] that increase binding
to a-actinin and FHL2, respectively, causing HCM; and
Y7621C [8] located in the A/I-band junction linked to restrictive
cardiomyopathies. Consequently, genetic screening of the titin
gene (TTN) is clinically relevant in most cardiomyopathy cases
[1,9]. However, while the robust discrimination between
benign and disease-causing titin truncations can be achieved
by coupling TTN exon inclusion data and the position of the
mutation within the gene [10], predicting the pathogenicity of
mSNPs in titin is considerably more complex. In contrast to trun-
cations, mSNPs might result in individual molecular
phenotypes and appear to trigger distinct pathomechanisms
[11]. As a result, the differentiation between benign and patho-
genic mSNP variants is currently very demanding, requiring
the integration of functional assays, robust bioinformatics,
large control cohorts and expert clinical evaluation [9].
In this work, we set to answer the question of whether
single mSNPs in titin can generically and without the contri-
bution of additional genetic factors lead to cardiac disease.
For this, we examined the unique mSNP T2850I in the I-band
domain of titin I10, as a paradigm of an alteration in a general
component of the titin chain. Domain I10 does not support
specific interactions or have any known specialized roles, so
it does not constitute an a priori sensitive locus of the chain.
The T2850I exchange has been associated with ARVC based
on linkage studies, being completely segregated with the
ARVC phenotype in nine patients from a large family, includ-
ing two fifth-degree relatives, and was absent in 300
cardiomyopathy and 400 control chromosomes [3]. ARVC is
characterized by life-threatening arrhythmias, being the main
cause of sudden death in the population below 25 years of
age. Mechanistically, ARVC is thought to result from a per-
turbed desmosomal force transmission [12]. Titin, however, is
an intrasarcomeric protein not known to be related to cell
adhesion. Thus, we asked whether mSNPs in titin can induce
an ARVC phenotype. In previous studies, we have shown
that the T2580I mSNP destabilizes the affected immunoglobu-
lin (Ig) domain in titin, I10, and speculated that this instability
increases the vulnerability of titin to proteolysis in situ poten-
tially leading to myocardial damage [3,13]. Here, we study
the dysfunction caused by this mutation by implementing an
integrative approach from the protein domain to the whole
organism. Results indicate that, in addition to fold instability,
the mSNP alters the chemical reactivity of titin leading to the
formation of non-native interactions in the sarcomere. Even
though the molecular and cellular effects of the exchange are
mild, they appear to lead to a detectable alteration of the dias-
tolic behaviour of the heart in knock-in (KI) mice. Thereby, our
results establish that a single SNP in a common Ig component
of titin can disturb the overall performance of the heart in theabsence of other genetic factors. The result points to a high
potential of titin mSNPs for causing cardiac disease.
2. Material and methods
T2850 is encoded by the ACC triplet on chromosome
2 : 178769890–178769893 referenced to GRCh38/hg38 human
genome assembly. This is mutation T2896I in Taylor et al. [3]
and mutation T16I in Anderson et al. [13].
For in vitro studies, I9–I11 (residues 2749–3009) and I10
(2835–2895) were expressed recombinantly in Escherichia coli
and purified to homogeneity by chromatography. For NMR
studies, I10 was produced in M9 medium with 15NH4Cl as
source of nitrogen and 13C-glucose as carbon source.
I10 crystals were grown in 0.2 M CaCl2, 0.1 M Tris pH 7.5
with either (a) 30% (w/v) PEG 3350, 3% (v/v) isopropanol or
(b) 25% (w/v) PEG 8000 as precipitants. Crystal (a) yielded a
crystallographic model to 2.00 Å resolution with an Rfactor/
Rfree ¼ 17.53/22.99%. Crystal (b) produced a model to 1.8 Å
and Rfactor/Rfree ¼ 17.45/20.49%. I19–I11 crystals were
produced in (c) 0.1 M Tris HCl pH 8.5, 30% (w/v) PEG 4000,
0.2 M MgCl2; (d) 0.1 M Bis-Tris propane pH 8.5, 20% (w/v)
PEG 3350, 0.2 M sodium acetate. A three-dimensional model
from (c) was to 1.9 Å with Rfactor/Rfree ¼ 19.28/22.83%; and
from (d) to 1.53 Å with an Rfactor/Rfree ¼ 16.15/19.65%. Struc-
tures have been deposited with the Protein Data Bank with
access codes: 4QEG, 5JDJ, 5JDE and 5JDD.
For molecular dynamic simulations, the crystal structure of
I10–I11 was used as wild-type and the T2850I modelled in
silico. A ‘protein in a box of water’ simulation of 50 ns followed
standard protocols in GROMACS 5.0. Principal component
analysis was used to analyse the trajectories for differences.
All animal experiments were approved by local ethics com-
mittees. T2850I mutation carrying mice were generated using
gene-targeting. Genotype was confirmed by direct sequencing.
The mice were on a mixed background, 50% 129S6 and 50%
C57BL/6. Echocardiography was performed under isoflurane
anaesthesia using a Vevo 2100 High-Resolution Imaging
System and accompanying software.
GFP-tagged titin fragments were introduced into tibialis
anterior muscle using electroporation under general anaesthesia.
Micewere sacrificed 10 days laterand transfected musclesections
visualized by laser scanning confocal microscopy for localization
of titin fragments or differential centrifugation of muscle extracts
was also performed. Tissue was fractionated into cytosolic,
microsomal and particulate fractions and titin fragments were
detected by western blotting using anti-GFP antibody.
Neonatal mouse cardiomyocytes were isolated from 1- to
3-day-old pups. Cells were transfected with GFP-tagged titin
fragments and fixed 48 h later. Cells were counterstained
with antibodies against a-actinin, filamentous actin and
DNA and imaged by confocal microscopy.
A comprehensive description of material and methods is
provided in the electronic supplementary material.3. Results
3.1. The T2850I mutation strongly destabilizes domain
I10
To estimate the effect of the T2850I exchange on the fold












































Figure 1. Crystal structure of I10 in isolation and in the context of the I9 – I11 tandem. (a) Representation of I10WT. The component b-sheets (A’FCC’G and ABED)
are coloured in red and blue, respectively. Residue T2850 in the A’B b-turn is indicated with a purple sphere; (b) structural features of the A’B b-turn of I10WT.
Hydrogen bonds are indicated by dashed lines; (c) Ramachandran plot showing that the main chain conformation of T2850 is located in the generously allowed left-
handed a-helical region (aL) (the electron density map of T2850 in electronic supplementary material, figure S2 shows that the conformation of this residue is
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monitored using differential scanning fluorimetry (DSF)
(electronic supplementary material, section S1). The melting
temperature (Tm) of I10
WT was derived from a single tran-
sition melting profile as 62.3+ 1.38C, in good agreement
with its Tm value previously calculated from circular dichro-
ism data (60.1+0.28C) [14]. This value indicates that I10 is an
intrinsically stable domain. The Tm value of I10
T2850I was
51.4+1.88C, approx. 118C below that of I10WT. Comparably
acute DTm decreases in titin Ig domains have only been obser-
ved when drastic truncations or modifications of the fold
occurred. Accordingly, our measurement of a truncated ver-
sion of I10 missing the N-terminal b-strand A showed a
DTm  2148C (electronic supplementary material, figure S1)
and the deletion of just four residues in other Igs of titin
decreased their Tm values by up to 158C [15,16]. A similar
DTm decrease was observed in domain Z1 when the CD
loop was replaced in its totality for an exogenous sequence
that eliminated b-strand C’ and, thereby, removed the native
capping of the Ig b-sandwich fold [17]. These data indicate
that the impact of the single-point mutation T2850I on I10 is
equivalent to that of a large insult on the fold, such as removal
of b-strand A or the CD loop. This significant destabiliz-
ing effect suggests that T2850 plays an important structural
role in I10.3.2. The crystal structure of I10 reveals a high-energy
conformation for residue T2850
To gain a molecular insight into the structural role of residue
T2850, we elucidated the atomic structure of domain I10 at
1.74 Å resolution using X-ray crystallography (diffraction
data statistics and model refinement parameters are given in
the electronic supplementary material, table S2). We calcula-
ted a total of 17 molecular copies of I10 originating from two
different space groups and diverse non-crystallographic sym-
metries. The structural features of all 17 molecular copies of
I10 were in strict agreement (global RMSD ¼ 0.62 Å for
82 matched Ca atoms across all models, calculated using
MUSTANG [18]). The structures showed that I10 displays a
classical Ig I-type fold (figure 1a) and that residue T2850 is
located at the C-terminal pole of the fold, in position i þ 2 of
the b-turn connecting b-strands A’ and B (experimental elec-
tron density shown in the electronic supplementary material,
figure S2). This is a b-turn type II, where residue i þ 2 adopts
a left-handed helix conformation (aL Ramachandran region)
that is sterically restricted [19]. T2850 is stabilized in this con-
formation by two hydrogen bonds (figure 1b): (i) a short,
strong bond (2.4 Å) between its side chain hydroxyl and the
carbonyl of the previous residue, E2849, and (ii) a second con-
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chain hydrogen bond turns the otherwise atomic clash
into a productive interaction and permits T2850 to adopt a
high-energy conformation within the generously allowed aL
Ramachandran region (figure 1c).
A side chain with a branched or cyclic Cb atom (such as that
of residues Ile, Val and Pro) in position i þ 2 could result in
clashes with the carbonyl group of the preceding i þ 1 residue
and, thereby, be sterically unsatisfactory. To investigate this
deduction, we carried out a study of 62 641 unique b-turns
type II naturally occurring in proteins using PDBeMotif [20]
(electronic supplementary material, table S3). We observed
that position i þ 1 is permissive to all residue types, but
that position i þ 2 strongly favours glycine (approx. 78% occur-
rence) with other amino acid types present at lower, but
significant frequencies. In agreement with our expectations,
amino acids with a branched Cb-atom are very rare in position
i þ 2: isoleucine is present only in 2 out of 62 641 cases (3 1025
occurrence), and valine in 22/62 641 (3.5  1024). Proline, with
a cyclic Cb-atom, is the most uncommon residue at 1/62 641
cases (1.5  1025). The few cases where proline or isoleucine
residues were found in position i þ 2 were examined manually
and found to correspond to exceptionally rare turns in internal
core positions, stabilized by rich hydrophobic contacts. Deduc-
tions from natural residue occurrence were in full agreement
with calculations of the differential free energy (DDG) of residue
tolerance in I10 using FoldX [21], which also proposed Ile,
Pro and Val as poorly tolerated residues at this locus of the
I10-fold (electronic supplementary material, figure S3).
Our conclusion is further supported by previous studies that
evaluated amino acid energetics and compositional potential
in type-II b-turns using small sample populations [19,22]. We
further observed that threonine residues at this position invari-
ably establish a tight hydrogen bond with the preceding main
chain carbonyl group. This hydrogen bond is not present in
b-turns II containing the Thr-resembling residues Ser and
Cys, indicating that this is a mechanism to specifically stabilize
the branched Cb-atom of Thr in that position.3.3. T2850I does not induce structural changes in I10
but increases its internal flexibility
The effect of the T2850I exchange on I10 was studied using
NMR. H1-N15 HSQC spectra of both wild-type and mutated
samples showed sharp, well-dispersed peaks characteristic of
folded proteins, revealing that the overall fold is preserved in
I10T2850I (figure 2a). However, a fraction of amide resonances
was perturbed by the mutation. Chemical shift perturbations
were quantified using a weighted average difference [23] and
regarded as ‘moderate’ (0.03 , DdAV , 0.15 ppm) or ‘large’
(DdAV . 0.15 ppm). They showed that in the 91 residue-long
I10T2850I, 6 residues underwent large and 10 residues moder-
ate chemical shift perturbations. When mapped onto the
crystal structure of I10, the perturbations largely clustered
around the mutation site, in the A’B b-turn and the neigh-
bouring EF loop that are interconnected through hydrogen
bonds mediated by T2850 (figure 2a). This shows that the
mutation only introduces modest local distortions in the I10-
fold. The characteristic backbone conformation of the A’B
turn with a positive main chain dihedral f angle in position
i þ 2 is best quantified by the measurement of the indirect coup-
ling constant 3 J(C’k21Hka). In this experiment, we observedsimilar couplings throughout the backbone of wild-type and
mutant samples and especially the large J-values characteristic
for the positive f angles of both Thr and Ile residues (figure 2b).
This indicated that the protein backbone conformations of both
wild-type and mutant are highly similar and that the exchange
does not notably affect the protein structure.
Next, we examined whether the T2850I mutation alters
the internal dynamics of the protein by measurement of
15N relaxation data. The ratio of transverse (R2) and longi-
tudinal (R1) relaxation rates gives a direct indication of the
internal backbone dynamics of an amino acid. The average
value of R2/R1 is determined by the overall rotational tum-
bling of the protein in solution and unaltered for most
regions in the wild-type and mutant proteins (figure 2c).
The outstanding exception are residues in the A’B b-turn
and the preceding b-strand A: here we observed a significant
increase in the R2/R1 ratios, which indicates that in the
mutated protein these residues are involved in a slow (micro-
second to millisecond timescale) structural exchange process
between a wild-type like ground state and one (or several)
altered conformations. Derivation of quantitative dynamical
parameters using the S2-order parameters, which is an indi-
cator of the fast timescale (picosecond to nanosecond),
reveals that backbone dynamics are very similar for wild-
type and mutant Ig10. Thus, it can be concluded that the
T2850I exchange increases internal domain flexibility not
only locally but that it has a knock-on effect on the preceding
secondary structure, loosening the N-terminal fraction of the
I10-fold, shown above to be important for the stability of I10.3.4. The crystal structure of I9 – I11 shows that T2850
mediates interdomain contacts
Residue T2850 is located at the C-terminal loop region of the Ig
fold. To study whether this region is involved in interactions
with the next Ig domain packed serially along the chain and,
thus, whether the T2850I exchange influences the Ig-tandem
architecture of titin, we determined the crystal structure of
I9–I11 (comprising I10 in its poly-domain context) to 1.53 Å res-
olution. Three molecular copies were obtained in two space
groups that agreed in showing I9–I11 in an extended confor-
mation (figure 1d). Such extended arrangements are common
in titin Ig-tandems [24,25]. In I9–I11, the component domains
follow a regular arrangement, where domains display relative
torsion angles of 458–688 and are connected by short, two-
residue sequences (TL and PI, respectively). In each Ig-pair, the
domain interface is consistently formed by the A’B b-turn of the
N-terminal domain slotting between the BC and FG loops of the
C-terminal domain. Here, domains interact directly through a
limited number of contacts (listed in the electronic supplementary
material, section S2). Both I9–I10 and I10–I11 interfaces consist
of a central hydrophobic residue contributed by the linker
sequence (TL; PI), flanked by two polar interactions between
loop residues from the neighbouring domains (figure 1d, inset).
In addition, electrostatic potential maps of single domains in
the I9–I11 tandem revealed that the N- and C-terminal poles of
all domains are, respectively, positively and negatively charged.
This suggests that an electrostatic component further assists
the organization of these Ig domains within the titin chain.
Residue T2850 is buried within the I10–I11 interface (burial
fraction of side chain is 0.79 as calculated with FoldX [21]). Here,
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Figure 2. NMR analysis of changes in I10 induced by the T2850I exchange. (a) H1 – N15 HSQC spectra (left). Residues affected by notable differences are indicated
and mapped on the crystal structure of I10 (right). It can be seen that significant changes only occur in the immediate vicinity of the T2850I exchange. (b) Measured
3J(C’k21Hak) values plotted against the f dihedral angle observed in the crystal structure of I10
WT. The blue curve shows the dependency of the coupling constant
upon the torsion angle f. Both wild-type and mutant show large J-couplings for residue 2850 characteristic for positive f angles. (c) Ratio of transverse (R2) and
longitudinal (R1) 15N relaxation rates (left). Values above the average can be mapped to the A’B b-turn and b-strand A (right; green). Here and throughout this
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hydrogen bonds with S2952 from the BC loop of I11. This
suggests that the exchange of the T2850 residue will cause a
local alteration of the conformational dynamics of the titin chain.3.5. The T2850I exchange alters the relative orientation
of domains in the chain
As residue T2850 is involved in both the intra- and interdomain
organization of titin, we studied next the effect of the T2850Iexchange on the conformational dynamics of the I10–I11
tandem using molecular dynamics simulations (MDS) (elec-
tronic supplementary material, section S4). In total, 50 ns
simulations were performed on the wild-type and on two
T2850I models that corresponded to two different rotamers
of the isoleucine residue. In addition, one wild-type and one
T2850I variant were repeated with a different water model.
The simulations were continued until no new conformational
space was sampled as reflected by principal component analy-
sis (electronic supplementary material, figure S4b–d). As a
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simulation on the Ig pair I65–I66 (extracted from PDB entry
3B4B [26]). In I65–I66, Ig domains are linked by a hydrophilic
linker, three residues long, that allows unrestricted motions.
This simulation confirmed that 50 ns simulation allows the
sampling of multiple extreme conformations (electronic
supplementary material, figure S4a).
Calculated trajectories for all I10–I11 models were con-
verted to backbone models and concatenated, then subjected
to covariance analysis. This showed that interdomain motions
could be largely described by the first three principal com-
ponent eigenvectors (PC1, PC2 and PC3), with PC1 and PC2
describing the largest movements. PC1 describes the rotational
movement of I10 with respect to I11 (which totals a range of
68o), while PC2 describes the bending opening between I10
and I11 (spanning a range of 65o). When PC1 and PC2 values
are plotted for all the trajectories, a difference in the confor-
mational space sampled by wild-type and T2850I mutant is
revealed—in particular, for the dominant component PC1
(figure 3a,b). Wild-type trajectories have more positive eigen-
values; in other words, inter-domain positions are aligned
straight along an imaginary axis connecting the two domains’
centres of mass, with both domains facing a similar starting
direction. Conversely, the trajectories for T2850I mutants
show negative eigenvalues that describe a greater degree of
twisting, where the I10 and I11 modules face different direc-
tions. In combination with other components of movement,
such as PC2’s bending, this results in the T2850I mutants
favouring a more bent and twisted conformation, that contrasts
with the more extended arrangement preferred by the wild-
type (figure 3b). This result suggests that wild-type and
mutant favour somewhat different areas of conformational
space, which might lead to titin acquiring different chemical
surface properties at the I10–I11 locus upon mutation.
3.6. The T2850I exchange affects the myocellular
reactivity of the titin Ig-tandem in vivo
To test whether the altered conformation of the T2850I-contain-
ing titin chain leads to an altered function in vivo, we assayed a
GFP-tagged I7–I13 titin fragment in its wild-type and mutated
versions in skeletal muscle of living mice. The fragment was
introduced into the tibialis anterior muscle by electropora-
tion and its expression monitored by western blot of muscle
extracts using an anti-GFP antibody (electronic supplementary
material, section S5). Single sharp protein bands correspond-
ing to the expected molecular weight of I7–I13 were revealed
this way. Signs of differential degradation of wild-type
and mutated forms were not evident. This did not agree with
a previous in vitro study, where recombinant I7–I13 and
I7–I13T2850I samples incubated with heart extracts indicated a
notably reduced half-life of the mutated variant, probably as
a result of proteolysis [13]. The findings in the current study
suggest that the proteases that acted on the recombinant
samples when extracts were used might not natively access
cytoplasmic samples in the myofibril (e.g. due to compartmen-
talization) or, alternatively, that the proteolytic components of
skeletal muscle are not representative of those from cardiac
tissue. Either way, the results did not bring further support
to in situ titin proteolysis as a mechanism of disease.
Imaging of the transfected muscles using in vivo confocal
light microscopy revealed a different myocellular localization
of wild-type and mutant I7–I13 (figure 3c). Wild-typefragments remained mostly soluble in the cytoplasm, associat-
ing only weakly with the sarcomere as suggested by the weak
striated pattern. Fixed sections of the GFP-I7–I13 transgenic
muscle that had been further stained with a fluorescent phall-
oidin conjugate (which binds F-actin forming the thin
filaments), revealed that wild-type I7–I13 associated with the
sarcomere in areas lacking F-actin, i.e. the H-zone of the A-
band. As the native location of I7–I13 within the titin chain is
the I-band, we concluded that the weak A-band patterning
resulted from unspecific interactions due to the elevated
expression levels. This result is not unexpected as previous
studies with recombinant titin fragments did not detect binding
of titin Ig-tandems to actin or other sarcomeric components
[28,29]. By contrast, I7–I13T2850I formed a well-defined striated
pattern. Phalloidin staining showed that I7–I13T2850I bands
colocalized with F-actin, at the I-band. However, subcellular
fractionation and actin co-sedimentation experiments showed
that the binding was not to actin itself or other primary sarco-
meric components (electronic supplementary material,
section S5). Unfortunately, efforts to identify the interactor
using pull-downs in muscle extracts and yeast two-hybrid
screens were not successful. Contrary to the transgenic mouse
muscle experiments, the transfection of mouse neonatal
cardiomyocytes with I7–I13 and I7–I13T2850I did not reveal
localization differences (figure 4). Both fragments remained
diffused in the cytoplasm under basal conditions and even
after isoproterenol stimulation (electronic supplementary
material, section S6). Neonatal cardiomyocytes have fully
developed sarcomeres but lack T-tubules, which make us
speculate that a T-tubule component might be the putative
target of the pathological interaction. Nonetheless, as the
I7–I13T2850I sarcomeric pattern agrees with the expected
native position of I7–I13, this pathologically increased affinity
for an I-band component is likely to be physiologically relevant
for this mSNP in its natural context within full-length titin.
3.7. Transgenic mice carrying the T2850I exchange
present enhanced diastolic stiffness
To determine whether the mutation has functional effects at
the organ level, we generated T2850I KI mice and performed
echocardiography. No differences were found in left ventricu-
lar chamber dimensions during diastole and systole, ejection
fraction or stroke volume (table 1). Pulse-wave Doppler echo-
cardiography was used to measure the velocity of diastolic
filling at the level of the mitral valve. Filling is known to
occur in two waves: early diastolic filling (E-wave) and late
diastolic filling due to atrial contraction (A-wave). The E/A
ratio is the ratio of the early (E) to late (A) ventricular filling vel-
ocities and reflects diastolic function. The E/A ratio is used as
an index for diastolic heart failure. Depending on the genetic
background of the mouse strain, the E/A ratio in mice is
1.25–1.6. For example, in FVB mice after a two-week long trans-
verse aortic constriction, which is a severe insult on the heart,
the E/A ratio increases from 1.26 to 2.5 [30]. In T2850I KI
mice, the E/A ratio was increased (from 1.67 in wild-type to
2.19 in the mutant) suggesting diastolic dysfunction. Further-
more, the E-wave deceleration time (DT) varies inversely
with left ventricular diastolic stiffness and is another measure
for the myocardial stiffening [31]. A significant E-wave DT
reduction was found in T2850I KI mice, further supporting
an increase in diastolic chamber stiffness. In conclusion,
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Figure 3. Different dynamic properties of wild-type and T2850I-mutated structures. (a) Molecular dynamics simulations of I10 – I11. Top: electrostatic surface rep-
resentation of conformational classes (using APBS [27]). Bottom: PC1 values plotted against PC2 values, showing static shift of relative conformations between
trajectories with a histogram of PC1 eigenvalue frequency; (b) cloud cartoon representation of trajectory snapshots at 0.5 ps intervals. The initial crystal structure
is shown as black ribbon. Throughout (a,b), T2850I is in gold and WT in green; (c) Differential localization in vivo of wild-type and mutant GFP-I7 – I13 samples.
Wild-type samples remained mostly diffused in the cytoplasm, with a weak association with the sarcomeric A-band as indicated by double-labelling with phalloidin.
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The genetic screening of the TTN gene, now pursued in large
patient populations, has the potential to assist the diagnosisof cardiomyopathies, assess prognosis and guide therapy.
However, identifying disease-causing missense alleles in titin
is challenging, with the unexpectedly large number of rare gen-
etic variants making their scoring a staggering task [32,33].





Figure 4. Expression of I7 – I13 samples in neonatal cardiomyocytes. Z-discs were stained with a-actinin (right panel, red in the overlay), filamentous actin with
fluorescent phalloidin (blue in the overlay), transfected titin fragments with EGFP (middle panel, green in the overlay) and nuclei with DAPI (white in the overlay).
Both, wild-type (WT CTL) and mutant fragments of titin (TI) remain mainly diffuse in the cytoplasm of neonatal cardiomyocytes. No striated pattern compatible with
sarcomeric targeting was observed, even in cells transfected with the wild-type construct that were challenged with 1 mM isoproterenol (ISO) for 6 h. Shown are
two representative cells for each condition. Scale bar, 40 mm.
Table 1. Cardiac parameters in T2850I transgenic mice. LVIDd: left
ventricular internal diastolic diameter; WTd: diastolic wall thickness (average
of posterior and anterior walls); LVIDs; left ventricular internal systolic
diameter; WTs: systolic wall thickness (average of posterior and anterior
walls); LV Vol; d: left ventricular diastolic volume; LV Vol; s: left ventricular
systolic volume; LVW: left ventricular weight (mg); EF: ejection fraction; SV:
stroke volume; MV E, mitral valve early diastolic peak filling velocity; MV A,
mitral valve late diastolic peak filling velocity; MV Decel: deceleration time
of E-wave (ms); MV E/A: ratio of MV E : MV A; LA: left atrium. p-value:
significance value calculated with t-test; *p , 0.05 (indicated in bold).
WT (n 5 7) T2850I (n 5 7) p-value
LVIDd (mm) 4.72+ 0.14 4.78+ 0.14 0.79
WTd (mm) 0.82+ 0.01 0.84+ 0.02 0.42
LVIDs (mm) 3.41+ 0.14 3.54+ 0.16 0.55
WTs (mm) 1.20+ 0.04 1.21+ 0.02 0.84
LV Vol;d (ml) 103.1+ 6.6 106.8+ 7.2 0.72
LV Vol;s (ml) 48.4+ 4.5 54.1+ 5.7 0.44
LVW 158+ 6 172+ 9 0.21
EF (%) 53.3+ 2.9 49.9+ 2.0 0.35
SV (ml) 54.8+ 4.2 52.6+ 2.6 0.67
MV E
(mm s21)
581+ 32 647+ 53 0.31
MV A
(mm s21)
351+ 22 300+ 26 0.15
MV Decel 30.3+ 0.8 26.5 + 1.1* 0.017
MV E/A 1.67+ 0.08 2.19 + 0.15* 0.011
E/E0 35.7+ 2.9 35.6+ 3.1 0.99
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thy in small patient families were found in 17% of the NHLBI
GO Exome Sequencing Project population [34], indicating
that association studies alone are insufficient to evaluate thepathological potential of rare variants. In addition, rare genetic
variants of sarcomeric genes often have complicated pene-
trance patterns. It was shown that the risk of adverse
cardiovascular events grows with increasing numbers of rare
sarcomeric variants [35]. Thus, methods are now urgently
needed that can improve mSNP classification and unleash
the wealth of information in TTN databases.
To gain an insight into the damage potential of mSNPs
in titin—in particular, in the heart that appears to be more sus-
ceptible to mutations than skeletal muscle—we have studied
the exchange T2850I in domain I10 of titin’s I-band, which
has been proposed to be linked to ARVC [3]. In this work,
we went beyond our initial clinical and biophysical character-
ization of the mutation [3,13] and explored manifestations of
this mSNP at different levels of biological complexity, ranging
from molecular to organismal levels. In this work, atomic res-
olution three-dimensional structures of the affected titin
region were generated as well as, to our knowledge, the first
mouse model of a cardiomyopathy-associated titin mSNP.
Our results show that the T2850I exchange only has a subtle
impact on the titin molecule as well as at the tissue and
animal levels. This was not anticipated, as it is intuitively
expected that the severity of the disease promoted by an
mSNP will correlate with the extent of the molecular damage
that it causes. Structural data (HSQC and 3J(C’k21Hka))
demonstrate that the T2850I exchange is tolerated by the I10-
fold, not causing any detectable structural aberration. How-
ever, DSF data show that the mutated domain is notably less
stable than the wild-type. The large difference in measured
thermal stability was difficult to understand, as the exchange
involves the removal of a single hydrogen bond (established
by the Thr side chain with the main chain of the preceding
residue; T2850-OH:CO-E2849) in the otherwise-intact fold.
However, NMR relaxation data showed that the exchange
not only increased the flexibility of the affected loop but also
of the preceding b-strand A. This N-terminal segment of the
fold is known to be of key importance for the chemical [26],
thermal [15,16] and mechanical stability of the fold [36]. Conse-
quently, our own measurement of an I10 variant lacking the





 on November 7, 2016http://rsob.royalsocietypublishing.org/Downloaded from comparable to that of the T2850I point mutant (electronic sup-
plementary material, section S1). That the mutated Ig is also
mechanically weaker has been established previously by
atomic force microscopy [13], so that its unfolding is likely to
occur at physiological muscle tension. The impact of an
unfolded Ig on the overall elasticity of the titin chain seems neg-
ligible. However, it was originally proposed [13] that Ig
unfolding (resulting from either stretch or spontaneous unfold-
ing due to the intrinsic weakness of the mutated domain)
might lead to in situ proteolysis of the titin chain, even
though depletion of mutated titin from sarcomeres was not
tested. In the current study, degradation of I7–I13 tandems
expressed in muscle was not apparent, suggesting that I10
unfolding might have other functional consequences. A recent
study has shown that induced unfolding of titin Ig segments
in cardiomyocytes results in elevated stiffness caused by the
aggregation of titin chains [37]. Yet, in diseased human muscle
and heart, HSP27 or ab-crystallin associates with the unfolded
modules, preventing aggregation and suppressing the stiffening
[37]. Hence, the extent to which I10 unfolding, specifically,
contributes to the T2850I pathology is unclear.
The second consequence of the mutation is at the chain
level, effected by its location in a domain junction. Our previous
characterization of titin segments showed that the properties of
domain interfaces are finely tuned along the chain, exhibiting
conserved features in different parts of the sarcomere [24,25].
Not surprisingly, MDS suggests that the T2850I exchange influ-
ences the conformational dynamics of the titin chain at that
locus, possibly altering its surface chemistry. An important
deduction from this work is that mutations located at domain
interfaces in titin can have an unexpected pathological poten-
tial, even when not causing major structural damage to the
component domains. This finding is in agreement with our
transgenic muscle data that point to the development of patho-
logical binding capacity in the mutated titin’s I-band in situ.
Interestingly, the differential sarcomeric localization of wild-
type and mutated samples could not be reproduced in neonatal
cardiomyocytes and further efforts to identify the possible inter-
actor of mutated titin failed. Upon differential centrifugation of
transgenic muscles extracts, titin fragments were solely found in
cytoplasmic and not in particulate myofibrillar or microsomal
fractions, implying a fragile nature of the pathological inter-
action. Speculatively, we consider the possibility that the
interaction might involve components of T-tubules as these
are absent in neonatal cardiomyocytes.
Interspecies conservation of the affected residue allowed us
to generate a knock-in mouse model carrying the titin T2850I
mSNP. Echocardiographic assessment revealed diastolic dys-
function in this mouse model, confirming that a single-point
mutation in titin can have a measurable effect in whole-heart
mechanics in the absence of any other genomic differences.However, no degenerative alterations in the left or right ventri-
cles were observed—thereby not reproducing the human
disease phenotype overall. Yet, it is possible that the fibrofatty
formations typically manifested at a clinical level in the second
or the third decade of life in ARVC patients are not appropri-
ately mimicked in mice. In fact, this appears to be also the
case in murine models of other non-titin-based ARVC types
(reviewed in [38]). Thus, there is a need for better biological sys-
tems to study ARVC. In this respect, new technologies such as
iPSC (induced pluripotent stem cell)-derived cardiomyocytes
need to be considered. This system has been applied to
the study of cardiomyopathies caused by titin truncating
mutations [39] and perhaps might be applicable to the study
of titin mSNPs. In ARVC, diastolic abnormalities are an early
marker of the disease [40], thus the mice model might mimic
initial stages of the human pathology. Speculatively, ‘sticki-
ness’ of Ig-tandems in titin’s I-band [28,29] (which natively
makes little or no connections to the thin filament during the
cardiac cycle) would interfere with its compliance, necessary
for efficient diastolic filling [41,42]. This could explain the
observed phenotype. Finally, there is the possibility that
the effect of the T2850I mutation in patients is potentiated by
another co-segregating genetic factor, jointly leading to the dis-
ease phenotype (e.g. an additive effect of other unknown rare
sarcomeric variants). In this regard, more complete genomic
analyses will be required in the future.
In conclusion, our results reveal that the contribution of a
single mSNP in a generic domain of titin can lead to a mea-
surable alteration of heart function, even though the mSNP
might only cause subtle changes at the protein level. Given
the staggering number of mSNPs in titin, this finding estab-
lishes the high potential of this protein to contribute to
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